Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Reading › NPI 1699734665
Hospital

ST Joseph Regional Health Network

ST Joseph Regional Health Network was paid $27.79M by Medicaid between Apr 2018 and Dec 2024, across 286 billing codes. Its largest line is 99284, emergency room visit (serious) — 22% of everything it billed.

33Billing provider infoST JOSEPH REGIONAL HEALTH NETWORK
READING, PA 19605
33aNPI1699734665assigned 03/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$27.79M
24GClaims483,848
24DCodes billed286
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#9 of 154
Median peer was paid$2.82M
This provider vs. median9.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201871$6K
20194,839$108K
202042,310$1.73M
2021189,643$8.30M
202288,071$6.37M
202397,801$6.52M
2024incomplete61,113$4.76M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 22% 22,195 21,600 $6.08M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 25,242 24,676 $4.78M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 10,100 9,754 $3.70M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 7.6% 17,627 17,366 $2.11M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.9% 7,822 7,437 $1.09M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.3% 2,405 2,357 $647K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.9% 5,960 5,742 $522K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 4,142 4,058 $463K
71046 Radiologic examination, chest; 2 views 1.5% 7,855 7,698 $421K
71045 Radiologic examination, chest; single view 1.3% 7,419 7,135 $364K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 2,892 1,602 $347K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.1% 5,171 4,649 $314K
274 more codes
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.0% 8,862 $278K
96375 Therapeutic injection; each additional sequential IV push <1% 6,868 $261K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 7,476 $247K
96361 Intravenous infusion, hydration; each additional hour <1% 5,716 $243K
59025 Fetal non-stress test <1% 1,844 $239K
80053 Comprehensive metabolic panel <1% 29,176 $237K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,268 $235K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 7,253 $228K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,014 $223K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 7,826 $165K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 31,212 $159K
G0378 Hospital observation service, per hour <1% 323 $157K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 286 $155K
36415 Collection of venous blood by venipuncture <1% 43,318 $148K
70450 Computed tomography, head or brain; without contrast material <1% 1,557 $136K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 929 $136K
80061 Lipid panel <1% 10,135 $132K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,501 $127K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 417 $111K
87480 <1% 4,347 $87K
87660 <1% 4,351 $86K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 442 $81K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,468 $75K
84443 Thyroid stimulating hormone (TSH) <1% 4,250 $75K
93975 <1% 434 $75K
87510 <1% 4,334 $71K
71275 Computed tomographic angiography, chest, with contrast material <1% 351 $68K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 227 $66K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,438 $65K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 1,073 $62K
76830 Ultrasound, transvaginal <1% 732 $58K
84702 <1% 5,626 $57K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 533 $57K
82728 <1% 4,080 $51K
83036 Hemoglobin; glycosylated (A1C) <1% 6,242 $51K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,951 $47K
97161 <1% 790 $45K
80050 General health panel <1% 2,256 $43K
86803 <1% 2,646 $41K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 728 $40K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,944 $40K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 813 $39K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 853 $38K
87490 <1% 1,581 $38K
87631 <1% 250 $38K
84484 <1% 3,421 $37K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 72 $34K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 486 $34K
G0475 Hiv antigen/antibody, combination assay, screening <1% 1,974 $34K
73564 <1% 678 $32K
96367 <1% 787 $32K
84466 <1% 2,392 $30K
80048 Basic metabolic panel (calcium, ionized) <1% 4,093 $30K
86696 <1% 1,562 $30K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 199 $28K
77063 Screening digital breast tomosynthesis, bilateral <1% 958 $27K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 93 $26K
73610 <1% 601 $26K
76642 <1% 453 $26K
83735 <1% 5,507 $26K
86900 <1% 543 $25K
73630 <1% 662 $25K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 605 $25K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 1,640 $24K
70551 Magnetic resonance imaging, brain; without contrast material <1% 117 $24K
93971 <1% 289 $23K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 762 $23K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,110 $23K
72141 <1% 86 $23K
77066 Tomosynthesis, mammo <1% 241 $23K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 433 $23K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 310 $23K
72110 <1% 480 $22K
77065 Tomosynthesis, mammo <1% 361 $22K
86480 <1% 299 $22K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 270 $21K
83655 <1% 1,709 $21K
73030 <1% 571 $21K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,598 $21K
87340 <1% 1,918 $20K
93970 <1% 148 $19K
93017 <1% 241 $19K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 776 $19K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 54 $19K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 219 $19K
83690 <1% 4,649 $19K
82607 <1% 1,606 $19K
76770 <1% 276 $18K
76801 <1% 232 $17K
87081 <1% 2,376 $17K
97162 <1% 275 $17K
83540 <1% 2,513 $16K
81001 <1% 7,031 $15K
73130 <1% 435 $15K
85027 <1% 2,284 $15K
86618 <1% 324 $15K
82150 <1% 3,873 $15K
72050 <1% 283 $15K
83525 <1% 1,180 $14K
76536 <1% 191 $14K
73110 <1% 402 $14K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 465 $14K
87150 <1% 302 $14K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 304 $13K
73562 <1% 334 $13K
97802 <1% 235 $13K
82784 <1% 513 $13K
80081 <1% 133 $12K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 164 $12K
93225 <1% 245 $12K
86003 <1% 148 $12K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 496 $12K
84439 <1% 1,181 $11K
86592 <1% 2,710 $11K
85610 <1% 2,993 $11K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 464 $11K
72100 <1% 209 $10K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 210 $10K
80074 <1% 142 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 126 $10K
82746 <1% 883 $9K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 366 $9K
62323 <1% 15 $9K
73502 <1% 220 $9K
74018 <1% 210 $8K
83970 <1% 210 $8K
71250 <1% 112 $8K
86038 <1% 497 $7K
84403 <1% 262 $7K
82570 <1% 1,051 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,139 $7K
80076 <1% 722 $6K
84146 <1% 285 $6K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 135 $6K
97803 <1% 231 $6K
84480 <1% 478 $6K
73221 <1% 26 $6K
87186 <1% 662 $6K
64483 <1% 18 $6K
36430 <1% 24 $5K
81003 <1% 2,349 $5K
73140 <1% 136 $5K
96417 <1% 68 $5K
93880 <1% 62 $5K
83001 <1% 257 $5K
82043 <1% 652 $5K
73080 <1% 140 $5K
86850 <1% 324 $5K
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening <1% 292 $5K
97165 <1% 92 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 239 $4K
95819 <1% 29 $4K
77085 <1% 71 $4K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 53 $4K
85018 <1% 1,338 $4K
85652 <1% 1,294 $4K
85014 <1% 1,332 $4K
83721 <1% 357 $4K
82077 <1% 133 $4K
86140 <1% 804 $3K
87077 <1% 409 $3K
76641 <1% 44 $3K
83002 <1% 163 $3K
83718 <1% 416 $3K
87040 <1% 241 $3K
86706 <1% 250 $3K
85730 <1% 566 $3K
86430 <1% 372 $3K
82330 <1% 266 $3K
86704 <1% 200 $3K
86901 <1% 320 $3K
82248 <1% 425 $3K
82397 <1% 673 $3K
A9585 Injection, gadobutrol, 0.1 ml <1% 467 $3K
80320 <1% 83 $2K
82950 <1% 385 $2K
86762 <1% 142 $2K
82565 <1% 486 $2K
85007 <1% 593 $2K
84100 <1% 423 $2K
83615 <1% 364 $2K
87147 <1% 333 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 69 $2K
87070 <1% 277 $2K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 215 $2K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 87 $2K
82947 <1% 468 $2K
84436 <1% 288 $2K
86787 <1% 133 $2K
82550 <1% 282 $2K
82465 <1% 439 $2K
80051 <1% 336 $2K
84153 <1% 76 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 153 $2K
82785 <1% 102 $2K
83605 <1% 278 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,483 $2K
84450 <1% 261 $2K
73590 <1% 47 $2K
84156 <1% 370 $2K
84402 <1% 54 $2K
71271 <1% 28 $1K
84460 <1% 235 $1K
81025 <1% 276 $1K
84520 <1% 361 $1K
83516 <1% 121 $1K
82670 <1% 50 $1K
82962 <1% 1,031 $1K
85379 <1% 132 $1K
84550 <1% 216 $1K
87088 <1% 145 $1K
96376 <1% 205 $1K
87522 Neg quan hep c or qual rna <1% 28 $1K
84481 <1% 54 $1K
94060 <1% 12 $1K
72072 <1% 16 $935.85
84165 <1% 71 $930.57
87205 <1% 204 $898.10
85378 <1% 105 $824.76
72082 <1% 12 $798.22
72070 <1% 14 $797.00
85046 <1% 119 $786.71
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 42 $752.75
82951 <1% 50 $747.54
97022 <1% 80 $732.42
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 113 $726.37
86200 <1% 39 $651.54
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,008 $650.55
83020 <1% 42 $604.03
87427 <1% 26 $602.77
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,844 $599.78
94760 <1% 241 $576.75
86235 <1% 17 $559.62
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,232 $540.63
90715 <1% 16 $420.85
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,731 $396.98
86703 <1% 15 $381.75
83883 <1% 39 $350.84
J2704 Injection, propofol, 10 mg <1% 1,557 $342.91
88304 <1% 29 $318.44
82627 <1% 13 $305.55
86617 <1% 12 $277.12
J1170 Injection, hydromorphone, up to 4 mg <1% 581 $272.83
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,526 $272.45
87045 <1% 25 $244.77
J3475 Injection, magnesium sulfate, per 500 mg <1% 110 $218.38
86160 <1% 14 $216.30
87341 <1% 24 $212.86
87046 <1% 25 $208.31
85660 <1% 40 $197.40
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 814 $131.72
82952 <1% 29 $121.56
J0690 Injection, cefazolin sodium, 500 mg <1% 613 $118.57
87328 <1% 12 $113.24
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,304 $77.82
J1644 Injection, heparin sodium, per 1000 units <1% 89 $43.93
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 933 $41.00
J8540 Dexamethasone, oral, 0.25 mg <1% 183 $32.80
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 58 $23.72
J2060 Injection, lorazepam, 2 mg <1% 74 $20.23
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,153 $12.22
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 69 $12.13
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 41 $11.48
3044F <1% 339 $0.03
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 180 $0.00
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 327 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 154 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 31 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 12 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 68 $0.00
3061F 0% 66 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 58 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 103 $0.00
J3490 Unclassified drugs 0% 32 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHABALOWSKI, EDWARD (CFO)
Same official

Other billing entities under CHABALOWSKI, EDWARD

Full network →
ProviderLocationPaid
ST. Joseph Medical GroupReading, PA$7.20M
ST Joseph Regional Health NetworkTemple, PA$1.02M
ST. Joseph Regional Health NetworkReading, PA$907K
ST Joseph Regional Health NetworkStrausstown, PA$236K
ST. Joseph Regional Health NetworkBlandon, PA$96K
ST. Joseph Regional Health NetworkReading, PA$91K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.